Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
By Karoline B. Kuchenbaecker, J. Hopper, Daniel R. Barnes, K. Phillips, T. Mooij, M. Roos-Blom, Sarah Jervis, F. V. van Leeuwen, R. Milne, N. Andrieu and 50 more. Journal of the American Medical Association (JAMA), 2017
2,592 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Oncology
View Paper: https://www.semanticscholar.org/paper/2b3250647b5765acc6425bba0f5022b25e30e038
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Genetics
In Oncology
Citations in the corpus
- DeepMiner: Discovering Interpretable Representations for Mammogram Classification and Explanation (2018, background): “Mutations in BRCA1 and BRCA2 are associated with an estimated life-time risk of breast cancer of approximately 70 percent (Kuchenbaecker et al., 2017), and patients carrying these mutations are recommended annual contrast-enhanced breast MRI exams in addition to screening mammography as well as the…”
- Epidemiological characteristics of and risk factors for breast cancer in the world (2019, background): “Based on a prospective cohort study, the risk of cumulative breast cancer by the age 80 years was 72% in the carriers of BRCA1 mutation (95% CI, 65%–79%), and this amount was 69% in the carriers of BRCA2 mutation (95% CI, 61%–77%).(77) Changes in human interferon α-2b may be involved in the onset an”
- Ovarian Cancer Statistics, 2018 (2018, background): “Among women with BRCA1 or BRCA2 mutations, the risk of developing ovarian cancer by age 80 years is 44% and 17%, respectively.(62) While these mutations are rare in the general population (less than 1%), they are more common in certain ethnic or geographically isolated groups, such as those of Ashke”